Search research articles
Contact Us
Filters
Showing results (251-260 of 266) with videos related to
Page
of 27
Sort By:
British Journal of Haematology
|
December 3, 1999
Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
E Di Bona, F Rodeghiero, B Bruno, et al.
Haematologica
|
January 1, 1997
Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO)
I Majolino, A M Cavallaro, A Bacigalupo, et al.
Leukemia
|
May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols
F Mandelli, R Latagliata, G Avvisati, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 26, 2006
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)
A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 6, 2007
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
A Tosetto, F Rodeghiero, G Castaman, et al.
Bone Marrow Transplantation
|
January 10, 2002
DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma
M Lazzarino, A Corso, L Barbarano, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 26, 2006
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD
J Eikenboom, V Van Marion, H Putter, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
U Budde, R Schneppenheim, J Eikenboom, et al.
Blood
|
August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups
M A Sanz, F Lo Coco, G Martín, et al.
Blood
|
August 1, 1997
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups
F Mandelli, D Diverio, G Avvisati, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 266) with videos related to
Sort By:
Page
of 27
British Journal of Haematology
|
December 3, 1999
Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
E Di Bona, F Rodeghiero, B Bruno, et al.
Haematologica
|
January 1, 1997
Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO)
I Majolino, A M Cavallaro, A Bacigalupo, et al.
Leukemia
|
May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols
F Mandelli, R Latagliata, G Avvisati, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 26, 2006
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)
A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 6, 2007
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
A Tosetto, F Rodeghiero, G Castaman, et al.
Bone Marrow Transplantation
|
January 10, 2002
DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma
M Lazzarino, A Corso, L Barbarano, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 26, 2006
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD
J Eikenboom, V Van Marion, H Putter, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
U Budde, R Schneppenheim, J Eikenboom, et al.
Blood
|
August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups
M A Sanz, F Lo Coco, G Martín, et al.
Blood
|
August 1, 1997
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups
F Mandelli, D Diverio, G Avvisati, et al.
Page
of 27